Hepatobiliary adverse drug reactions associated with remdesivir: The WHO international pharmacovigilance study

Kim, Min Seo and Jung, Se Yong and Lee, Seung Won and Li, Han and Koyanagi, Ai and Kronbichler, Andreas and Dragioti, Elena and Tizaoui, Kalthoum and Wasuwanich, Paul and Hong, Sung Hwi and Ghayda, Ramy A. and Yoo, Hae Won and Kim, Hanna and Jacob, Louis and Salem, Joe-Elie and Kostev, Karel and Shin, Youn Ho and Kim, So Young and Gamerith, Gabriele and Yon, Dong Keon and Shin, Jae Il and Smith, Lee (2021) Hepatobiliary adverse drug reactions associated with remdesivir: The WHO international pharmacovigilance study. Clinical Gastroenterology and Hepatology, 19 (9). pp. 1970-1972. ISSN 1542-3565

[img]
Preview
Text
Accepted Version
Available under the following license: Creative Commons Attribution Non-commercial No Derivatives.

Download (382kB) | Preview
[img] Text (Word version)
Accepted Version
Available under the following license: Creative Commons Attribution Non-commercial No Derivatives.

Download (49kB)
Official URL: https://doi.org/10.1016/j.cgh.2021.04.039
Item Type: Journal Article
Keywords: remdesivir, Hepatobiliary adverse drug reactions, WHO, COVID-19
Faculty: COVID-19 Research Collection
Faculty of Science & Engineering
SWORD Depositor: Symplectic User
Depositing User: Symplectic User
Date Deposited: 28 Apr 2021 15:23
Last Modified: 30 Apr 2022 01:02
URI: https://arro.anglia.ac.uk/id/eprint/706532

Actions (login required)

Edit Item Edit Item